MODERN BIOMARKERS OF CORONARY HEART DISEASE
loading.default
item.page.files
item.page.date
item.page.authors
item.page.journal-title
item.page.journal-issn
item.page.volume-title
item.page.publisher
Web of Journals Publishing
item.page.abstract
An ideal biomarker of acute myocardial infarction (AMI) should be sensitive and specific early in the course of the disease and have a high prognostic value, which could help clinicians to choose the most optimal treatment tactics. To date, there is no ideal biomarker of AMI, which would have all the characteristics at the same time.